We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
11 hedge funds and large institutions have $22.1M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
12% more capital invested
Capital invested by funds: $19.7M → $22.1M (+$2.39M)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$7.76M |
| 2 |
TFCP
Twin Focus Capital Partners
Boston,
Massachusetts
|
+$49.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.16K |
Top Sellers
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$199K |
| 2 |
Goldman Sachs
New York
|
-$81K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$48K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$535 |